SlideShare a Scribd company logo
 
Objectives of the study ,[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object]
Frequency of Respiratory Distress Syndrome ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Percentage of Term and Preterm newborn  Total 30 patients: Boys 20(67%) & Girls 10(30%) 5
Body weight of patients
Pathologic events in RDS Rosario N. Santos--Chua, et al ,  UpToDate , 2009.
Investigation of Respiratory Distress Syndrome in newborn
Radiographic appearance of children in Respiratory Distress Syndrome ,[object Object]
Differential Diagnosis of  Respiratory Distress Syndrome ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
11
Treatment of Respiratory Distress Syndrome ,[object Object],[object Object],[object Object],[object Object],[object Object]
Surfactant therapy Alveofact, Curosurf, Infasurg, Survanta  Curosurf Dosage: Intratracheal: Initial: 2.5 mL/kg/dose (200 mg/kg/dose); may repeat 1.25 mL/kg/dose (100 mg/kg/dose); at 12-hour intervals for up to 2 additional doses; maximum total dose: 5 mL/kg. Curosurf   It produces rapid improvements in lung oxygenation and compliance that may require immediate reductions in ventilator settings and FiO2.
Surfactant versus placebo treatment from  Liechty EA; et al, July 1991.
Differences between the percentage of following cases in Newborn’s Department and NICU
Antibiotic usage for newborn’s 3 diseases in following department *3 diseases are Aspiration pneumonia, Respiratory distress syndrome & Congenital pneumonia. Pt.no= Patient’s number Pt.no Pt.no Pt.no Antibiotics in NICU (N=21) Antibiotics in Newborn Department  (N=9) Antibiotics in Newborn department after treated from NICU  (N=21) Netilmicin  ( Нетилмицин ) 13 Cefotaxime   (Клафоран) 8 Ceftriaxone 10 Ceftriaxone  ( Роцефин ) 13 Fluconazole 2 Ciprofloxacin 8 Ciprofloxacin  ( Ципробай ) 10 Amikacin 1 Fluconazole 7 Vancomycin  ( Ванкомицин ) 6   Netilmicin 4 Fluconazole   ( Дифлюкан ) 6   Vancomycin 2 Metronidazole   (Метрогил) 5   Metronidazole 2 Ceftazidime   (Фортум) 4   Ceftazidime 1 Rifampicin   (Рифампицин) 3   Imipenem   (Имипенем) 1 Amikacin   (Амикацин) 3   Imipenem+Cilastatin   (Тиенам) 1     Linezolide   (Линизолед) 1    
Differences between antibiotics combination  in Newborn Department, Newborn Department after treated from NICU and NICU
Combine antibiotic treatment according to  following diseases
CPAP and Mechanical Ventilation
Duration of stay in Neonatal Intensive Care Unit and Newborn’s department NICU Newborn’s department duration 20
Conclusion ,[object Object],[object Object],[object Object],[object Object]
Tanl power point
Tanl power point

More Related Content

What's hot

Treating Asthma in Pregnancy
Treating Asthma in Pregnancy Treating Asthma in Pregnancy
Treating Asthma in Pregnancy
Kharima SD
 
Asthma in Pregnancy
Asthma in PregnancyAsthma in Pregnancy
Asthma in Pregnancy
La Lura White
 
Asthma in pregnancy Dr Muhammad Akram Khan Qaim Khani
Asthma in pregnancy Dr Muhammad Akram Khan Qaim KhaniAsthma in pregnancy Dr Muhammad Akram Khan Qaim Khani
Asthma in pregnancy Dr Muhammad Akram Khan Qaim Khani
Muhammad Akram
 
Asthma in Pregnancy
Asthma in PregnancyAsthma in Pregnancy
Asthma in Pregnancy
Niranjan Chavan
 
Bronchial asthama and pregnancys
Bronchial asthama and pregnancysBronchial asthama and pregnancys
Bronchial asthama and pregnancysdrmcbansal
 
Case Study On Asthma
Case Study On Asthma Case Study On Asthma
Case Study On Asthma
Zohaib HUSSAIN
 
Presentation on pathogen of meningitis.siam (ppt file)
Presentation on pathogen of meningitis.siam (ppt file)Presentation on pathogen of meningitis.siam (ppt file)
Presentation on pathogen of meningitis.siam (ppt file)
Kamruzzaman Siam
 
2 genetic susceptibility to bronchial asthma
2 genetic susceptibility to bronchial asthma2 genetic susceptibility to bronchial asthma
2 genetic susceptibility to bronchial asthma
Hiba Ashibany
 
Reducing the Incidence of Chronic Lung Disease in Very Premature Infants with...
Reducing the Incidence of Chronic Lung Disease in Very Premature Infants with...Reducing the Incidence of Chronic Lung Disease in Very Premature Infants with...
Reducing the Incidence of Chronic Lung Disease in Very Premature Infants with...amir mohammad Armanian
 
Asthma management phenotype based approach
Asthma management phenotype based approachAsthma management phenotype based approach
Asthma management phenotype based approachGamal Agmy
 

What's hot (11)

Treating Asthma in Pregnancy
Treating Asthma in Pregnancy Treating Asthma in Pregnancy
Treating Asthma in Pregnancy
 
Asthma in Pregnancy
Asthma in PregnancyAsthma in Pregnancy
Asthma in Pregnancy
 
Asthma in pregnancy Dr Muhammad Akram Khan Qaim Khani
Asthma in pregnancy Dr Muhammad Akram Khan Qaim KhaniAsthma in pregnancy Dr Muhammad Akram Khan Qaim Khani
Asthma in pregnancy Dr Muhammad Akram Khan Qaim Khani
 
Asthma in pregnancy
Asthma in pregnancyAsthma in pregnancy
Asthma in pregnancy
 
Asthma in Pregnancy
Asthma in PregnancyAsthma in Pregnancy
Asthma in Pregnancy
 
Bronchial asthama and pregnancys
Bronchial asthama and pregnancysBronchial asthama and pregnancys
Bronchial asthama and pregnancys
 
Case Study On Asthma
Case Study On Asthma Case Study On Asthma
Case Study On Asthma
 
Presentation on pathogen of meningitis.siam (ppt file)
Presentation on pathogen of meningitis.siam (ppt file)Presentation on pathogen of meningitis.siam (ppt file)
Presentation on pathogen of meningitis.siam (ppt file)
 
2 genetic susceptibility to bronchial asthma
2 genetic susceptibility to bronchial asthma2 genetic susceptibility to bronchial asthma
2 genetic susceptibility to bronchial asthma
 
Reducing the Incidence of Chronic Lung Disease in Very Premature Infants with...
Reducing the Incidence of Chronic Lung Disease in Very Premature Infants with...Reducing the Incidence of Chronic Lung Disease in Very Premature Infants with...
Reducing the Incidence of Chronic Lung Disease in Very Premature Infants with...
 
Asthma management phenotype based approach
Asthma management phenotype based approachAsthma management phenotype based approach
Asthma management phenotype based approach
 

Similar to Tanl power point

Taquipnea transitoria del recién nacido: Que hay de nuevo?
Taquipnea transitoria del recién nacido: Que hay de nuevo?Taquipnea transitoria del recién nacido: Que hay de nuevo?
Taquipnea transitoria del recién nacido: Que hay de nuevo?
Frank Cajina Gómez
 
Pneumonia in children
Pneumonia in childrenPneumonia in children
Pneumonia in children
Thorsang Chayovan
 
Asthma and pregnancy
Asthma and pregnancyAsthma and pregnancy
Asthma and pregnancy
raghu srikanti
 
Op RDS
Op RDSOp RDS
Op RDS
om prakash
 
management of neonatal sepsis
management of neonatal sepsismanagement of neonatal sepsis
management of neonatal sepsis
Osama Elfiki
 
Respiratory disorders in pregnancy
Respiratory disorders in pregnancyRespiratory disorders in pregnancy
Respiratory disorders in pregnancy
dr.hafsa asim
 
Pregnancy in Dermatomyositis Complicated with Covid
Pregnancy in Dermatomyositis Complicated with CovidPregnancy in Dermatomyositis Complicated with Covid
Pregnancy in Dermatomyositis Complicated with Covid
International Journal of Medical and Pharmaceutical Research
 
Respiratory distress in neonates
Respiratory distress in neonatesRespiratory distress in neonates
Respiratory distress in neonates
Stacy A.J
 
MANAGEMENT OF PRETERM LABOUR:ATOSIBAN
MANAGEMENT OF PRETERM LABOUR:ATOSIBANMANAGEMENT OF PRETERM LABOUR:ATOSIBAN
MANAGEMENT OF PRETERM LABOUR:ATOSIBAN
NARENDRA C MALHOTRA
 
falla respiratoria.pdf
falla respiratoria.pdffalla respiratoria.pdf
falla respiratoria.pdf
MASIELAMELIABARRANTE
 
Respiratory Disorders In Pregnancy 26092023.pptx
Respiratory Disorders In Pregnancy 26092023.pptxRespiratory Disorders In Pregnancy 26092023.pptx
Respiratory Disorders In Pregnancy 26092023.pptx
Niranjan Chavan
 
Bronchopulmonary dysplasia updates_and_prevention dr falakha
Bronchopulmonary dysplasia updates_and_prevention dr falakhaBronchopulmonary dysplasia updates_and_prevention dr falakha
Bronchopulmonary dysplasia updates_and_prevention dr falakha
gfalakha
 
RDS-.pptx
RDS-.pptxRDS-.pptx
RDS-.pptx
asst professer
 
Safety of neuraminidase inhibitors in pregnant and breastfeeding women tanaka...
Safety of neuraminidase inhibitors in pregnant and breastfeeding women tanaka...Safety of neuraminidase inhibitors in pregnant and breastfeeding women tanaka...
Safety of neuraminidase inhibitors in pregnant and breastfeeding women tanaka...Ruth Vargas Gonzales
 
ROP prevention at NICU.pptx
ROP prevention at NICU.pptxROP prevention at NICU.pptx
ROP prevention at NICU.pptx
Arijit Bhowmik
 
Prophylactic Aminophylline for Prevention of Apnea at Higher-Risk Preterm Neo...
Prophylactic Aminophylline for Prevention of Apnea at Higher-Risk Preterm Neo...Prophylactic Aminophylline for Prevention of Apnea at Higher-Risk Preterm Neo...
Prophylactic Aminophylline for Prevention of Apnea at Higher-Risk Preterm Neo...amir mohammad Armanian
 
Respiratory Failure in the Pregnant Patient
Respiratory Failure in the Pregnant PatientRespiratory Failure in the Pregnant Patient
Respiratory Failure in the Pregnant Patient
Dr.Mahmoud Abbas
 
seminar on bronco pulmonary dysplasia
seminar on bronco pulmonary dysplasiaseminar on bronco pulmonary dysplasia
seminar on bronco pulmonary dysplasia
Dr. Habibur Rahim
 
Neonatal sepsis
Neonatal sepsisNeonatal sepsis
Neonatal sepsis
TheShraddha
 

Similar to Tanl power point (20)

Taquipnea transitoria del recién nacido: Que hay de nuevo?
Taquipnea transitoria del recién nacido: Que hay de nuevo?Taquipnea transitoria del recién nacido: Que hay de nuevo?
Taquipnea transitoria del recién nacido: Que hay de nuevo?
 
Pneumonia in children
Pneumonia in childrenPneumonia in children
Pneumonia in children
 
Asthma and pregnancy
Asthma and pregnancyAsthma and pregnancy
Asthma and pregnancy
 
Op RDS
Op RDSOp RDS
Op RDS
 
management of neonatal sepsis
management of neonatal sepsismanagement of neonatal sepsis
management of neonatal sepsis
 
Respiratory disorders in pregnancy
Respiratory disorders in pregnancyRespiratory disorders in pregnancy
Respiratory disorders in pregnancy
 
Pregnancy in Dermatomyositis Complicated with Covid
Pregnancy in Dermatomyositis Complicated with CovidPregnancy in Dermatomyositis Complicated with Covid
Pregnancy in Dermatomyositis Complicated with Covid
 
Respiratory distress in neonates
Respiratory distress in neonatesRespiratory distress in neonates
Respiratory distress in neonates
 
MANAGEMENT OF PRETERM LABOUR:ATOSIBAN
MANAGEMENT OF PRETERM LABOUR:ATOSIBANMANAGEMENT OF PRETERM LABOUR:ATOSIBAN
MANAGEMENT OF PRETERM LABOUR:ATOSIBAN
 
falla respiratoria.pdf
falla respiratoria.pdffalla respiratoria.pdf
falla respiratoria.pdf
 
Respiratory Disorders In Pregnancy 26092023.pptx
Respiratory Disorders In Pregnancy 26092023.pptxRespiratory Disorders In Pregnancy 26092023.pptx
Respiratory Disorders In Pregnancy 26092023.pptx
 
Bronchopulmonary dysplasia updates_and_prevention dr falakha
Bronchopulmonary dysplasia updates_and_prevention dr falakhaBronchopulmonary dysplasia updates_and_prevention dr falakha
Bronchopulmonary dysplasia updates_and_prevention dr falakha
 
RDS-.pptx
RDS-.pptxRDS-.pptx
RDS-.pptx
 
Safety of neuraminidase inhibitors in pregnant and breastfeeding women tanaka...
Safety of neuraminidase inhibitors in pregnant and breastfeeding women tanaka...Safety of neuraminidase inhibitors in pregnant and breastfeeding women tanaka...
Safety of neuraminidase inhibitors in pregnant and breastfeeding women tanaka...
 
ROP prevention at NICU.pptx
ROP prevention at NICU.pptxROP prevention at NICU.pptx
ROP prevention at NICU.pptx
 
Prophylactic Aminophylline for Prevention of Apnea at Higher-Risk Preterm Neo...
Prophylactic Aminophylline for Prevention of Apnea at Higher-Risk Preterm Neo...Prophylactic Aminophylline for Prevention of Apnea at Higher-Risk Preterm Neo...
Prophylactic Aminophylline for Prevention of Apnea at Higher-Risk Preterm Neo...
 
Respiratory Failure in the Pregnant Patient
Respiratory Failure in the Pregnant PatientRespiratory Failure in the Pregnant Patient
Respiratory Failure in the Pregnant Patient
 
Dizdar et al., 2011
Dizdar et al., 2011Dizdar et al., 2011
Dizdar et al., 2011
 
seminar on bronco pulmonary dysplasia
seminar on bronco pulmonary dysplasiaseminar on bronco pulmonary dysplasia
seminar on bronco pulmonary dysplasia
 
Neonatal sepsis
Neonatal sepsisNeonatal sepsis
Neonatal sepsis
 

Recently uploaded

Chapter -12, Antibiotics (One Page Notes).pdf
Chapter -12, Antibiotics (One Page Notes).pdfChapter -12, Antibiotics (One Page Notes).pdf
Chapter -12, Antibiotics (One Page Notes).pdf
Kartik Tiwari
 
The French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free downloadThe French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free download
Vivekanand Anglo Vedic Academy
 
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
Nguyen Thanh Tu Collection
 
Digital Artifact 2 - Investigating Pavilion Designs
Digital Artifact 2 - Investigating Pavilion DesignsDigital Artifact 2 - Investigating Pavilion Designs
Digital Artifact 2 - Investigating Pavilion Designs
chanes7
 
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
EugeneSaldivar
 
S1-Introduction-Biopesticides in ICM.pptx
S1-Introduction-Biopesticides in ICM.pptxS1-Introduction-Biopesticides in ICM.pptx
S1-Introduction-Biopesticides in ICM.pptx
tarandeep35
 
Guidance_and_Counselling.pdf B.Ed. 4th Semester
Guidance_and_Counselling.pdf B.Ed. 4th SemesterGuidance_and_Counselling.pdf B.Ed. 4th Semester
Guidance_and_Counselling.pdf B.Ed. 4th Semester
Atul Kumar Singh
 
Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.
Ashokrao Mane college of Pharmacy Peth-Vadgaon
 
Digital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and ResearchDigital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and Research
Vikramjit Singh
 
Best Digital Marketing Institute In NOIDA
Best Digital Marketing Institute In NOIDABest Digital Marketing Institute In NOIDA
Best Digital Marketing Institute In NOIDA
deeptiverma2406
 
The approach at University of Liverpool.pptx
The approach at University of Liverpool.pptxThe approach at University of Liverpool.pptx
The approach at University of Liverpool.pptx
Jisc
 
Unit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdfUnit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdf
Thiyagu K
 
2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
Sandy Millin
 
Marketing internship report file for MBA
Marketing internship report file for MBAMarketing internship report file for MBA
Marketing internship report file for MBA
gb193092
 
CACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdfCACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdf
camakaiclarkmusic
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
DeeptiGupta154
 
A Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in EducationA Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in Education
Peter Windle
 
Embracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic ImperativeEmbracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic Imperative
Peter Windle
 
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup   New Member Orientation and Q&A (May 2024).pdfWelcome to TechSoup   New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
TechSoup
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
Celine George
 

Recently uploaded (20)

Chapter -12, Antibiotics (One Page Notes).pdf
Chapter -12, Antibiotics (One Page Notes).pdfChapter -12, Antibiotics (One Page Notes).pdf
Chapter -12, Antibiotics (One Page Notes).pdf
 
The French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free downloadThe French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free download
 
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
 
Digital Artifact 2 - Investigating Pavilion Designs
Digital Artifact 2 - Investigating Pavilion DesignsDigital Artifact 2 - Investigating Pavilion Designs
Digital Artifact 2 - Investigating Pavilion Designs
 
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
 
S1-Introduction-Biopesticides in ICM.pptx
S1-Introduction-Biopesticides in ICM.pptxS1-Introduction-Biopesticides in ICM.pptx
S1-Introduction-Biopesticides in ICM.pptx
 
Guidance_and_Counselling.pdf B.Ed. 4th Semester
Guidance_and_Counselling.pdf B.Ed. 4th SemesterGuidance_and_Counselling.pdf B.Ed. 4th Semester
Guidance_and_Counselling.pdf B.Ed. 4th Semester
 
Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.
 
Digital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and ResearchDigital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and Research
 
Best Digital Marketing Institute In NOIDA
Best Digital Marketing Institute In NOIDABest Digital Marketing Institute In NOIDA
Best Digital Marketing Institute In NOIDA
 
The approach at University of Liverpool.pptx
The approach at University of Liverpool.pptxThe approach at University of Liverpool.pptx
The approach at University of Liverpool.pptx
 
Unit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdfUnit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdf
 
2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
 
Marketing internship report file for MBA
Marketing internship report file for MBAMarketing internship report file for MBA
Marketing internship report file for MBA
 
CACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdfCACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdf
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
 
A Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in EducationA Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in Education
 
Embracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic ImperativeEmbracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic Imperative
 
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup   New Member Orientation and Q&A (May 2024).pdfWelcome to TechSoup   New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
 

Tanl power point

  • 1.  
  • 2.
  • 3.
  • 4.
  • 5. Percentage of Term and Preterm newborn Total 30 patients: Boys 20(67%) & Girls 10(30%) 5
  • 6. Body weight of patients
  • 7. Pathologic events in RDS Rosario N. Santos--Chua, et al , UpToDate , 2009.
  • 8. Investigation of Respiratory Distress Syndrome in newborn
  • 9.
  • 10.
  • 11. 11
  • 12.
  • 13. Surfactant therapy Alveofact, Curosurf, Infasurg, Survanta Curosurf Dosage: Intratracheal: Initial: 2.5 mL/kg/dose (200 mg/kg/dose); may repeat 1.25 mL/kg/dose (100 mg/kg/dose); at 12-hour intervals for up to 2 additional doses; maximum total dose: 5 mL/kg. Curosurf It produces rapid improvements in lung oxygenation and compliance that may require immediate reductions in ventilator settings and FiO2.
  • 14. Surfactant versus placebo treatment from Liechty EA; et al, July 1991.
  • 15. Differences between the percentage of following cases in Newborn’s Department and NICU
  • 16. Antibiotic usage for newborn’s 3 diseases in following department *3 diseases are Aspiration pneumonia, Respiratory distress syndrome & Congenital pneumonia. Pt.no= Patient’s number Pt.no Pt.no Pt.no Antibiotics in NICU (N=21) Antibiotics in Newborn Department (N=9) Antibiotics in Newborn department after treated from NICU (N=21) Netilmicin ( Нетилмицин ) 13 Cefotaxime (Клафоран) 8 Ceftriaxone 10 Ceftriaxone ( Роцефин ) 13 Fluconazole 2 Ciprofloxacin 8 Ciprofloxacin ( Ципробай ) 10 Amikacin 1 Fluconazole 7 Vancomycin ( Ванкомицин ) 6   Netilmicin 4 Fluconazole ( Дифлюкан ) 6   Vancomycin 2 Metronidazole (Метрогил) 5   Metronidazole 2 Ceftazidime (Фортум) 4   Ceftazidime 1 Rifampicin (Рифампицин) 3   Imipenem (Имипенем) 1 Amikacin (Амикацин) 3   Imipenem+Cilastatin (Тиенам) 1     Linezolide (Линизолед) 1    
  • 17. Differences between antibiotics combination in Newborn Department, Newborn Department after treated from NICU and NICU
  • 18. Combine antibiotic treatment according to following diseases
  • 19. CPAP and Mechanical Ventilation
  • 20. Duration of stay in Neonatal Intensive Care Unit and Newborn’s department NICU Newborn’s department duration 20
  • 21.